Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Effects of Functional Electrical Stimulation Combined With Task-Oriented Training on Lower Limb Function, Balance, and Quality of Life in Children With Spastic Diplegic Cerebral Palsy.

3 novembre 2026 mis à jour par: Prof. Dr. Shoaib Waqas, Lahore University of Biological and Applied Sciences

This study aims to compare the effects of Functional Electrical Stimulation (FES) combined with Task-Oriented Training (TOT) and Task-Oriented Training alone on gross motor function, balance, and quality of life in children with spastic diplegic cerebral palsy. Children with this condition commonly experience lower-limb weakness, increased muscle tone, impaired balance, and difficulties with standing and walking.

A total of 44 children aged 3-7 years will be recruited. Participants will be randomly allocated into two groups: the experimental group will receive FES combined with task-oriented training, while the control group will receive task-oriented training alone. Both groups will undergo supervised treatment three times per week for six weeks, with each session lasting 60 minutes.

The experimental group will receive FES applied to the gluteus medius muscle alongside task-oriented training. Task-oriented training will include sit-to-stand practice, standing balance, walking, stepping, obstacle negotiation, and stair training. Outcomes will be assessed before and after the intervention using the Gross Motor Function Measure (GMFM), Pediatric Balance Scale (PBS), Pediatric Functional Independence Measure (WeeFIM), and Pediatric Quality of Life Inventory (PedsQL). The study aims to determine whether combining FES with task-oriented training leads to greater improvements in gross motor function, balance, and quality of life.

Aperçu de l'étude

Description détaillée

Spastic diplegic cerebral palsy is a subtype of cerebral palsy characterized by predominantly lower-limb involvement, often resulting in increased muscle tone, muscle weakness, impaired selective motor control, and difficulties with standing, walking, balance, and functional mobility. These impairments can restrict children's participation in daily activities and negatively affect their functional independence and quality of life. Routine physiotherapy is commonly used to address these limitations; however, improvements in basic motor performance may not always translate into better performance of functional activities requiring coordinated movement, postural stability, and dynamic balance. Therefore, rehabilitation approaches that combine targeted muscle activation with repetitive, goal-directed functional practice may offer additional benefits for children with spastic diplegic cerebral palsy.

Functional Electrical Stimulation (FES) uses controlled electrical impulses to stimulate peripheral motor nerves and produce muscle contraction. When appropriately applied during functional activities, FES may facilitate muscle activation and support movement performance. Task-Oriented Training (TOT) is a rehabilitation approach based on repetitive practice of meaningful, goal-directed activities designed to improve motor learning, functional performance, and the transfer of acquired skills into everyday activities. Combining FES with TOT may provide additional benefits by facilitating targeted muscle activation while children practice functional movements. However, evidence regarding the combined effects of FES and task-oriented training on lower-limb function, balance, and quality of life in young children with spastic diplegic cerebral palsy remains limited. This study is designed to address this gap by comparing the effects of FES combined with TOT and TOT alone.

This study will be conducted as a two-arm, parallel-group randomized clinical trial involving 44 children aged 3-7 years with spastic cerebral palsy who meet the predefined eligibility criteria. Participants will be randomly allocated to either the experimental group or the control group in a 1:1 ratio. A computer-generated randomization sequence will be prepared by an independent researcher who will not be involved in participant recruitment, treatment, or outcome assessment. Allocation concealment will be maintained using sequentially numbered, opaque, sealed envelopes. Participants will undergo a six-week intervention program consisting of three supervised sessions per week, with each session lasting 60 minutes. The experimental group will receive Functional Electrical Stimulation combined with Task-Oriented Training, while the control group will receive Task-Oriented Training alone. The FES intervention will target the gluteus medius muscle to facilitate muscle activation during standing and functional movement activities. Electrical stimulation will be delivered using a frequency of 35 Hz, a pulse width of 250 microseconds, a ramp time of 1-2 seconds, and an on-to-off ratio of 1:3. Stimulation intensity will be adjusted according to the child's tolerance to achieve visible and comfortable muscle contractions.

Task-Oriented Training will involve progressive, structured practice of functional activities selected to address standing control, weight shifting, stepping, walking, dynamic balance, and functional mobility. During the first week, training will focus on sit-to-stand transitions, standing weight shifts in side-to-side and forward-backward directions, and level-surface walking. During the second week, activities will progress to overground walking, step initiation, and forward and lateral stepping. The third week will include obstacle crossing, stepping over floor markers, and multidirectional stepping to challenge dynamic balance and movement coordination. During the fourth week, participants will practice step-ups, stair negotiation, and tandem walking. The fifth week will incorporate changes in walking direction, variations in walking speed, and dual-task walking activities. During the sixth week, training will progress to advanced gait activities, obstacle negotiation, and simulated community mobility tasks according to each child's functional ability and tolerance.

The primary outcome will be gross motor function, assessed using the Gross Motor Function Measure (GMFM-88), with particular consideration of standing and walking-related abilities. Secondary outcomes will include balance, functional independence, and health-related quality of life. Balance will be evaluated using the Pediatric Balance Scale (PBS), functional independence using the Pediatric Functional Independence Measure (WeeFIM), and health-related quality of life using the Pediatric Quality of Life Inventory (PedsQL). These outcome measures will be used to determine whether combining FES with task-oriented training produces greater improvements than task-oriented training alone.

Outcome assessments will be conducted at baseline (Week 0) before the intervention begins and immediately after completion of the six-week intervention program (Week 6). Changes in gross motor function, balance, functional independence, and quality of life will be evaluated within and between the two groups to determine the effectiveness of the interventions.

The findings of this study may provide evidence regarding the effectiveness of combining Functional Electrical Stimulation with Task-Oriented Training in improving lower-limb function, balance, functional independence, and quality of life in children with spastic diplegic cerebral palsy.

Type d'étude

Interventionnel

Inscription (Estimé)

44

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

    • Punjab Province
      • Lahore, Punjab Province, Pakistan
        • Recrutement
        • Ghurki Trust and Teaching Hospital

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

3 ans à 7 ans (Enfant)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Children of either gender, aged 3-7 years, diagnosed with spastic cerebral palsy - Gross Motor Function Classification System (GMFCS) Levels II and III
  • Ability to understand and follow simple verbal instructions with or without auditory device

Exclusion Criteria:

  • Botulinum toxin injection to the lower limbs within the previous 6 months .
  • Severe fixed contractures or musculoskeletal deformities affecting gait .
  • Uncontrolled epilepsy or other neurological disorders besides cerebral palsy .
  • Cardiac pacemakers or other implanted electrical devices contraindicating FES use.
  • Severe visual, auditory, or cognitive impairments preventing participation.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Functional Electrical Stimulation + Task-Oriented Training

Group A will receive Functional Electrical Stimulation (FES) combined with Task-Oriented Training (TOT) for six weeks. FES will be applied to the gluteus medius muscle during functional activities to facilitate muscle activation. Participants will also perform progressive task-oriented activities, including sit-to-stand practice, standing weight shifts, walking, stepping, obstacle negotiation, and stair training. Sessions will be delivered three times per week for six weeks, with each session lasting 60 minutes.

Participants will receive Functional Electrical Stimulation combined with Task-Oriented Training for six weeks, with three supervised sessions per week (18 sessions in total, 60 minutes each). FES will be applied to the gluteus medius, Hamstring, quadriceps muscle using a frequency of 35 Hz, a pulse width of 250 μs, a ramp time of 1-2 seconds, and an on-to-off ratio of 1:3. Stimulation intensity will be adjusted to produce a visible, comfortable muscle contraction. Task-oriented training will include progressive functional activities such as sit-to-stand practice, standing weight shifting, level walking, stepping, obstacle negotiation, step-ups, stair training, and advanced gait activities.

Comparateur actif: Task- Oriented Training

Group B will receive routine physical therapy along with Task-Oriented Training (TOT) for six weeks. Participants will practice progressive functional activities designed to improve gross motor function, balance, and functional mobility. Training will include sit-to-stand practice, standing weight shifts, overground walking, forward and lateral stepping, obstacle crossing, step-ups, stair negotiation, changes in walking direction, and advanced gait activities. Sessions will be delivered three times per week for six weeks, with each session lasting 60 minutes.

Participants will receive Task-Oriented Training for six weeks, with three supervised sessions per week (18 sessions in total, 60 minutes each). Training will involve progressive, goal-directed functional activities to improve gross motor function, balance, and functional mobility. Activities will progress from sit-to-stand practice, standing weight shifting, and level walking to multidirectional stepping, obstacle crossing, step-ups, stair negotiation, changes in walking direction, variations in walking speed, and advanced gait activities according to participants' abilities.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Gross motor function (Gross Motor Function Measure-88)
Délai: Baseline (Week 0) and post-intervention (Week 6).

The Gross Motor Function Measure (GMFM-88) is a standardized observational assessment used to evaluate gross motor function in children with cerebral palsy. This study will focus on Dimension D (Standing) and Dimension E (Walking, Running, and Jumping). Scores range from 0% to 100%, with higher scores indicating better gross motor function.

Baseline (Week 0) and post-intervention (Week 6).
Functional independence (Pediatric Functional Independence Measure)
Délai: Baseline (Week 0) and post-intervention (Week 6).

The Pediatric Functional Independence Measure (WeeFIM) assesses a child's level of independence in self-care, mobility, and cognition. Total scores range from 18 to 126, with higher scores indicating greater functional independence.

Baseline (Week 0) and post-intervention (Week 6).
Balance (Pediatric Balance Scale)
Délai: Baseline (Week 0) and post-intervention (Week 6).

The Pediatric Balance Scale (PBS) assesses functional balance during everyday activities in children. Total scores range from 0 to 56, with higher scores indicating better balance performance.

Baseline (Week 0) and post-intervention (Week 6).
Health-related quality of life (Pediatric Quality of Life Inventory)
Délai: Baseline (Week 0) and post-intervention (Week 6).

The Pediatric Quality of Life Inventory (PedsQL) evaluates health-related quality of life across physical, emotional, social, and school functioning domains. Scores range from 0 to 100, with higher scores indicating better quality of life.

Baseline (Week 0) and post-intervention (Week 6).

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Directeur d'études: Dr. Shoaib Waqas, PHD, Lahore University of Biological and Applied Sciences

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

12 octobre 2026

Achèvement primaire (Estimé)

30 décembre 2026

Achèvement de l'étude (Estimé)

1 janvier 2027

Dates d'inscription aux études

Première soumission

3 novembre 2026

Première soumission répondant aux critères de contrôle qualité

3 novembre 2026

Première publication (Réel)

9 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

9 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

3 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner